We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Spring Regulatory Agenda Adds Proposed Rule on Compounded Drug Distribution
FDA’s Spring Regulatory Agenda Adds Proposed Rule on Compounded Drug Distribution
The FDA has released its Spring 2022 regulatory agenda, pushing back the timing of several previously announced proposed and final rules, and signaling its intention to issue a proposed rule on compounded drug products by the end of the year.